In 2010, the world’s most expensive therapy was Soliris (eculizumab), costing around USD 409,500 p...
Read moreA €3 million invoice for a single infusion can dazzle as easily as it alarms. Gene therapies such ...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreThe committee’s recommendations are forwarded to the Federal Ministry of Health for consideration.
Read moreThe Patented Medicine Prices Review Board (PMPRB) has a mandate to ensure that patented medicines ar...
Read moreA one stop shop for joint advice between EMA, EUnetHTA and health technology assessment bodies - the...
Read more